Eisai’s Alzheimer’s drug Leqembi set for China rollout
Eisai plans to introduce its groundbreaking Alzheimer's drug, Leqembi, to 1,500 people in China this year, with expectations of significant growth in 2025 as diagnosis methods...
Search the newsroom
Press Enter to search or Esc to close.
Category
Eisai plans to introduce its groundbreaking Alzheimer's drug, Leqembi, to 1,500 people in China this year, with expectations of significant growth in 2025 as diagnosis methods...
In a recent announcement, the French National Medicines Safety Agency (ANSM) has raised concerns about the use of oral vasoconstrictor medications commonly used to relieve nasal...